Quarterly report pursuant to Section 13 or 15(d)

Note 7 - STOCKHOLDERS' DEFICIT (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights

v3.19.1
Note 7 - STOCKHOLDERS' DEFICIT (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]    
Balance Outstanding, Number of Shares 402,250 402,250
Balance Outstanding, Weighted Average Exercise Price (in Dollars per share) $ 0.40 $ 0.40
Balance Outstanding, Weighted Average Remaining Contractual Term 4 years 175 days 4 years 262 days
Balance Outstanding, Aggregate Intrinsic Value (in Dollars) $ 0 $ 0
Granted 0  
Forfeited 0  
Exercised 0  
Expired 0  
Balance Outstanding, Number of Shares 402,250 402,250
Balance Outstanding, Weighted Average Remaining Contractual Term 4 years 175 days 4 years 262 days
Balance Outstanding, Aggregate Intrinsic Value (in Dollars) $ 0 $ 0
Balance Exercisable, Number of Shares 402,250  
Balance Exercisable, Weighted Average Exercise Price (in Dollars per share) $ 0.40  
Balance Exercisable, Weighted Average Remaining Contractual Term 4 years 175 days  
Balance Exercisable, Aggregate Intrinsic Value (in Dollars) $ 0